AlphaStocks
5.4
Consider Buy

HEALTHEQUITY, INC. (HQY)

Health Care / Managed Health Care

S&P MidCap 400

$95.19

Below average on several measures. Research carefully.

Consider Buy

Score based on 5 of 5 models — high confidence

#437out of 1121 in Health Care

Is HEALTHEQUITY, INC. a Good Investment in 2026?

HEALTHEQUITY, INC. (HQY) scores 5.4 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Piotroski model rates HEALTHEQUITY, INC. as Strong (9/9). However, the Graham model rates it Caution — Significantly above fair value. HEALTHEQUITY, INC. currently trades above its estimated fair value of $66, suggesting limited upside at current prices. HEALTHEQUITY, INC. ranks #437 out of 1121 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E38.7ROE10.1Market Cap8B

Estimated Fair Value

$65.6045% above

Trading above estimated fair value. P/e of 39x implies high growth expectations. rapid eps growth (126%) partially justifies the premium.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Strong

9/9

Buffett

Attractive

Business quality & competitive moat

Graham

Caution

Significantly above fair value

Lynch

Neutral

PEG 3.2 · Stalwart

Greenblatt

Neutral

Top 25% (rank 10%)

Frequently Asked Questions

Is HEALTHEQUITY, INC. (HQY) a good investment?
Based on AlphaStocks' composite analysis, HEALTHEQUITY, INC. (HQY) scores 5.4 out of 10, earning a Consider Buy rating. This score is below average, suggesting caution. Trading above estimated fair value. P/e of 39x implies high growth expectations. rapid eps growth (126%) partially justifies the premium.
What is HEALTHEQUITY, INC.'s Piotroski F-Score?
HEALTHEQUITY, INC.'s Piotroski F-Score status is Strong. The raw score is 9/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is HQY overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $66, HQY appears overvalued. The stock currently trades 45% above its estimated fair value. Trading above estimated fair value. P/e of 39x implies high growth expectations. rapid eps growth (126%) partially justifies the premium.
How does HQY compare to other Health Care stocks?
HEALTHEQUITY, INC. ranks #437 out of 1121 stocks in the Health Care sector, placing it in the top 39% of its sector by composite score. This is an above-average position relative to sector peers.
What do investment models say about HQY?
AlphaStocks evaluates HQY using five proven investment models. Piotroski: Strong; Buffett: Attractive; Graham: Caution; Lynch: Neutral; Greenblatt Magic Formula: Neutral. These models are combined into a single composite score of 5.4/10.

Similar Stocks

PARRBFAMAZN

Compare HQY with

HQY vs PARRHQY vs BFAMHQY vs AZN

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer